Analyzing Tumor Cells for PD-L1 by IHC

Recorded On: 11/21/2018

  • Registration Closed

PD-L1 is a protein that allows some cells to escape an attack by the immune system. Analyzing tumor cells for PD-L1 by IHC helps determine if patients will benefit from immune checkpoint inhibitors (cancer drugs). This webinar will discuss this protein and will include IHC technique, clinical features, and challenges and issues.

CEUs: This histology course is worth 1 continuing education credit. Course is available for 365 days from date of purchase. 

Sherita Meyer-Gausen

Chief Histologist

Sherita specializes in translational molecular pathology with emphasis in immunohistochemistry. She also consults with researchers and clinicians regarding clinical trials and research protocols. She is also a clinical preceptor with MD Anderson’s School of Health Professions.

Key:

Complete
Failed
Available
Locked
Analyzing Tumor Cells for PD-L1 by IHC
Open to view video.
Open to view video. PD-L1 is a protein that allows some cells to escape an attack by the immune system. Analyzing tumor cells for PD-L1 by IHC helps determine if patients will benefit from immune checkpoint inhibitors (cancer drugs). This webinar will discuss this protein and will include IHC technique, clinical features, and challenges and issues.
You must register to access.
On Demand Webinar Survey
2 Questions
2 Questions Please complete the survey to receive your CEU certificate.
You must register to access.
Certificate
1.00 CEU credit  |  Certificate available
1.00 CEU credit  |  Certificate available
You must register to access.